Christopher Gignoux
Concepts (360)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genetics, Population | 30 | 2023 | 192 | 3.220 |
Why?
| Genome, Human | 24 | 2023 | 352 | 2.080 |
Why?
| Genome-Wide Association Study | 33 | 2023 | 1217 | 1.970 |
Why?
| Polymorphism, Single Nucleotide | 46 | 2023 | 1918 | 1.850 |
Why?
| Genetic Variation | 17 | 2022 | 877 | 1.690 |
Why?
| Genetic Predisposition to Disease | 22 | 2023 | 2125 | 1.330 |
Why?
| Genomics | 18 | 2024 | 645 | 1.320 |
Why?
| Asthma | 19 | 2019 | 2066 | 1.080 |
Why?
| Precision Medicine | 4 | 2024 | 344 | 1.070 |
Why?
| Models, Genetic | 11 | 2022 | 570 | 1.070 |
Why?
| Genetics, Medical | 5 | 2023 | 24 | 0.970 |
Why?
| Pharmacogenetics | 2 | 2021 | 151 | 0.840 |
Why?
| Biological Specimen Banks | 5 | 2024 | 95 | 0.840 |
Why?
| Gastritis | 1 | 2023 | 84 | 0.810 |
Why?
| Enteritis | 1 | 2023 | 82 | 0.810 |
Why?
| Desogestrel | 1 | 2021 | 40 | 0.750 |
Why?
| Transcriptome | 4 | 2023 | 736 | 0.710 |
Why?
| Haplotypes | 20 | 2022 | 457 | 0.690 |
Why?
| Human Migration | 6 | 2021 | 19 | 0.690 |
Why?
| Gene Flow | 8 | 2020 | 76 | 0.650 |
Why?
| Eosinophilic Esophagitis | 1 | 2023 | 295 | 0.640 |
Why?
| Chromosomes, Human, Pair 18 | 1 | 2018 | 11 | 0.640 |
Why?
| Smad2 Protein | 1 | 2018 | 33 | 0.640 |
Why?
| Humans | 116 | 2024 | 115587 | 0.600 |
Why?
| Genotype | 23 | 2022 | 1786 | 0.580 |
Why?
| Gene Frequency | 12 | 2023 | 485 | 0.560 |
Why?
| Multifactorial Inheritance | 6 | 2023 | 125 | 0.530 |
Why?
| Chromosome Mapping | 11 | 2023 | 489 | 0.520 |
Why?
| Population | 2 | 2014 | 28 | 0.500 |
Why?
| DNA, Mitochondrial | 6 | 2016 | 185 | 0.490 |
Why?
| Population Growth | 2 | 2012 | 9 | 0.490 |
Why?
| Metagenomics | 4 | 2023 | 131 | 0.490 |
Why?
| Indians, North American | 7 | 2021 | 584 | 0.460 |
Why?
| Receptors, KIR | 5 | 2022 | 92 | 0.450 |
Why?
| Mexican Americans | 7 | 2023 | 101 | 0.450 |
Why?
| Agriculture | 2 | 2011 | 78 | 0.430 |
Why?
| Genetic Loci | 7 | 2019 | 264 | 0.400 |
Why?
| Exome | 5 | 2022 | 202 | 0.390 |
Why?
| Evolution, Molecular | 5 | 2021 | 440 | 0.390 |
Why?
| Molecular Epidemiology | 3 | 2023 | 66 | 0.360 |
Why?
| Indians, South American | 2 | 2020 | 22 | 0.360 |
Why?
| Pedigree | 3 | 2021 | 467 | 0.360 |
Why?
| Computational Biology | 3 | 2023 | 536 | 0.350 |
Why?
| Genetic Association Studies | 3 | 2022 | 343 | 0.340 |
Why?
| Population Groups | 2 | 2020 | 58 | 0.330 |
Why?
| Linkage Disequilibrium | 9 | 2023 | 247 | 0.330 |
Why?
| Quantitative Trait Loci | 5 | 2023 | 313 | 0.320 |
Why?
| Phenotype | 12 | 2023 | 2829 | 0.310 |
Why?
| Alleles | 10 | 2022 | 794 | 0.310 |
Why?
| Skin Pigmentation | 2 | 2018 | 39 | 0.310 |
Why?
| Selection, Genetic | 4 | 2019 | 243 | 0.300 |
Why?
| Environmental Exposure | 3 | 2017 | 378 | 0.290 |
Why?
| Receptors, KIR2DL1 | 2 | 2018 | 18 | 0.280 |
Why?
| Gene-Environment Interaction | 3 | 2023 | 184 | 0.280 |
Why?
| Mexico | 8 | 2023 | 163 | 0.280 |
Why?
| Genetic Markers | 7 | 2023 | 325 | 0.280 |
Why?
| Female | 42 | 2022 | 59913 | 0.280 |
Why?
| Colorado | 4 | 2024 | 4113 | 0.270 |
Why?
| Phylogeography | 5 | 2020 | 45 | 0.270 |
Why?
| Minority Groups | 2 | 2019 | 230 | 0.260 |
Why?
| Delivery of Health Care | 2 | 2023 | 844 | 0.260 |
Why?
| Phylogeny | 7 | 2022 | 805 | 0.250 |
Why?
| Gene Expression Profiling | 3 | 2020 | 1536 | 0.250 |
Why?
| Killer Cells, Natural | 4 | 2021 | 383 | 0.240 |
Why?
| Young Adult | 12 | 2022 | 10470 | 0.240 |
Why?
| Puerto Rico | 8 | 2021 | 52 | 0.240 |
Why?
| Heterozygote | 3 | 2021 | 252 | 0.230 |
Why?
| Chromosomes, Human, Pair 6 | 3 | 2014 | 44 | 0.230 |
Why?
| Genes, MHC Class I | 2 | 2021 | 32 | 0.230 |
Why?
| Thyroid Nodule | 1 | 2024 | 37 | 0.220 |
Why?
| Male | 39 | 2023 | 55949 | 0.220 |
Why?
| Algorithms | 3 | 2023 | 1490 | 0.220 |
Why?
| Proteins | 2 | 2022 | 920 | 0.210 |
Why?
| Receptors, KIR3DS1 | 1 | 2022 | 6 | 0.200 |
Why?
| Immunoglobulin E | 2 | 2014 | 328 | 0.200 |
Why?
| Receptors, KIR3DL1 | 1 | 2022 | 16 | 0.200 |
Why?
| Emigration and Immigration | 3 | 2013 | 44 | 0.200 |
Why?
| Risk Factors | 14 | 2023 | 8697 | 0.200 |
Why?
| Myocardial Ischemia | 1 | 2023 | 237 | 0.200 |
Why?
| Collagen Type VII | 1 | 2021 | 13 | 0.200 |
Why?
| Demography | 5 | 2018 | 261 | 0.200 |
Why?
| Jews | 1 | 2021 | 19 | 0.200 |
Why?
| Epidermolysis Bullosa Dystrophica | 1 | 2021 | 21 | 0.190 |
Why?
| Adolescent | 18 | 2021 | 17889 | 0.190 |
Why?
| Pharmacogenomic Variants | 1 | 2021 | 34 | 0.190 |
Why?
| History, Medieval | 3 | 2021 | 41 | 0.190 |
Why?
| Uterine Hemorrhage | 1 | 2021 | 35 | 0.190 |
Why?
| Drug Implants | 1 | 2021 | 71 | 0.190 |
Why?
| Islands | 1 | 2020 | 4 | 0.180 |
Why?
| Indians, Central American | 1 | 2020 | 5 | 0.180 |
Why?
| Thyroid Neoplasms | 1 | 2024 | 262 | 0.180 |
Why?
| Latin America | 2 | 2018 | 69 | 0.180 |
Why?
| Self Report | 2 | 2021 | 698 | 0.180 |
Why?
| Population Health | 1 | 2021 | 45 | 0.180 |
Why?
| Pre-Eclampsia | 1 | 2022 | 165 | 0.180 |
Why?
| Reference Standards | 1 | 2020 | 161 | 0.170 |
Why?
| Case-Control Studies | 9 | 2022 | 3022 | 0.170 |
Why?
| Adaptation, Biological | 1 | 2020 | 54 | 0.170 |
Why?
| Lipase | 1 | 2020 | 66 | 0.170 |
Why?
| Triglycerides | 2 | 2023 | 473 | 0.170 |
Why?
| Inflammatory Bowel Diseases | 1 | 2023 | 289 | 0.170 |
Why?
| Data Interpretation, Statistical | 1 | 2021 | 324 | 0.170 |
Why?
| Human Genetics | 1 | 2019 | 2 | 0.170 |
Why?
| Obesity | 2 | 2023 | 2517 | 0.160 |
Why?
| Apolipoprotein L1 | 1 | 2018 | 12 | 0.160 |
Why?
| Geographic Mapping | 1 | 2019 | 21 | 0.160 |
Why?
| Coronary Artery Disease | 2 | 2023 | 607 | 0.160 |
Why?
| Oligonucleotide Array Sequence Analysis | 3 | 2017 | 746 | 0.160 |
Why?
| Liver Diseases | 1 | 2021 | 263 | 0.160 |
Why?
| Antiporters | 1 | 2018 | 18 | 0.160 |
Why?
| Europe | 5 | 2020 | 336 | 0.160 |
Why?
| United States | 15 | 2021 | 12295 | 0.160 |
Why?
| Proteome | 1 | 2022 | 345 | 0.160 |
Why?
| Feasibility Studies | 1 | 2021 | 741 | 0.150 |
Why?
| Atherosclerosis | 1 | 2022 | 341 | 0.150 |
Why?
| Chromosomes, Human, Y | 2 | 2008 | 14 | 0.150 |
Why?
| Microbiota | 2 | 2023 | 652 | 0.150 |
Why?
| HLA-C Antigens | 1 | 2018 | 33 | 0.150 |
Why?
| Primates | 1 | 2019 | 111 | 0.150 |
Why?
| Weight Gain | 1 | 2021 | 453 | 0.150 |
Why?
| Fibrillar Collagens | 1 | 2017 | 12 | 0.150 |
Why?
| Collagen Diseases | 1 | 2017 | 6 | 0.150 |
Why?
| Dermatitis, Atopic | 1 | 2021 | 310 | 0.150 |
Why?
| Computer Simulation | 5 | 2022 | 881 | 0.150 |
Why?
| Patient Acceptance of Health Care | 1 | 2023 | 682 | 0.150 |
Why?
| Apolipoprotein A-V | 1 | 2017 | 3 | 0.150 |
Why?
| Epistasis, Genetic | 1 | 2017 | 69 | 0.150 |
Why?
| Saliva | 2 | 2020 | 189 | 0.140 |
Why?
| Gene Pool | 2 | 2013 | 5 | 0.140 |
Why?
| Women's Health | 1 | 2019 | 271 | 0.140 |
Why?
| History, Ancient | 3 | 2013 | 51 | 0.140 |
Why?
| Adult | 15 | 2021 | 30718 | 0.140 |
Why?
| Colorectal Neoplasms | 1 | 2023 | 617 | 0.140 |
Why?
| Language | 2 | 2011 | 258 | 0.140 |
Why?
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 246 | 0.140 |
Why?
| Homozygote | 3 | 2023 | 186 | 0.140 |
Why?
| Aged | 9 | 2023 | 19251 | 0.140 |
Why?
| Research Design | 1 | 2022 | 946 | 0.130 |
Why?
| DNA Methylation | 2 | 2017 | 498 | 0.130 |
Why?
| Colombia | 3 | 2021 | 36 | 0.130 |
Why?
| Kidney Diseases | 1 | 2018 | 354 | 0.120 |
Why?
| Social Class | 2 | 2013 | 210 | 0.120 |
Why?
| Premature Birth | 1 | 2018 | 278 | 0.120 |
Why?
| Genealogy and Heraldry | 1 | 2013 | 5 | 0.120 |
Why?
| Child | 15 | 2020 | 18488 | 0.120 |
Why?
| Health Surveys | 1 | 2016 | 446 | 0.120 |
Why?
| Pandemics | 1 | 2022 | 1334 | 0.110 |
Why?
| Africa, Southern | 3 | 2018 | 8 | 0.110 |
Why?
| Membrane Proteins | 1 | 2020 | 1024 | 0.110 |
Why?
| Ikaros Transcription Factor | 1 | 2014 | 18 | 0.110 |
Why?
| Air Pollution | 1 | 2016 | 172 | 0.110 |
Why?
| Minority Health | 1 | 2013 | 20 | 0.110 |
Why?
| Emigrants and Immigrants | 1 | 2016 | 111 | 0.110 |
Why?
| Population Dynamics | 2 | 2012 | 128 | 0.110 |
Why?
| RNA-Binding Proteins | 1 | 2017 | 362 | 0.110 |
Why?
| Urban Health | 1 | 2013 | 75 | 0.110 |
Why?
| Search Engine | 1 | 2013 | 10 | 0.110 |
Why?
| Nasal Mucosa | 1 | 2014 | 94 | 0.110 |
Why?
| Kv Channel-Interacting Proteins | 1 | 2013 | 3 | 0.110 |
Why?
| Neanderthals | 1 | 2013 | 8 | 0.110 |
Why?
| Albuterol | 1 | 2013 | 105 | 0.110 |
Why?
| Hypersensitivity, Immediate | 1 | 2013 | 47 | 0.110 |
Why?
| Carrier Proteins | 1 | 2017 | 701 | 0.110 |
Why?
| Chromosomes, Human, Pair 19 | 1 | 2012 | 22 | 0.110 |
Why?
| Principal Component Analysis | 1 | 2013 | 177 | 0.110 |
Why?
| Kallikreins | 1 | 2012 | 30 | 0.110 |
Why?
| HLA-DQ beta-Chains | 1 | 2012 | 59 | 0.100 |
Why?
| Forced Expiratory Volume | 2 | 2013 | 516 | 0.100 |
Why?
| Biological Evolution | 2 | 2019 | 417 | 0.100 |
Why?
| Respiratory Function Tests | 2 | 2012 | 535 | 0.100 |
Why?
| Cross-Sectional Studies | 1 | 2022 | 4435 | 0.100 |
Why?
| United Kingdom | 2 | 2023 | 227 | 0.100 |
Why?
| Breast Neoplasms | 2 | 2014 | 1872 | 0.100 |
Why?
| Prostate-Specific Antigen | 1 | 2012 | 151 | 0.100 |
Why?
| Tuberculosis | 1 | 2014 | 244 | 0.100 |
Why?
| Lung | 2 | 2016 | 3672 | 0.100 |
Why?
| Mycobacterium tuberculosis | 1 | 2014 | 271 | 0.100 |
Why?
| Bronchodilator Agents | 1 | 2013 | 249 | 0.100 |
Why?
| HLA-B Antigens | 2 | 2022 | 56 | 0.100 |
Why?
| History, 17th Century | 1 | 2011 | 16 | 0.100 |
Why?
| History, 15th Century | 1 | 2011 | 12 | 0.100 |
Why?
| Polynesia | 2 | 2021 | 3 | 0.100 |
Why?
| History, 18th Century | 1 | 2011 | 20 | 0.100 |
Why?
| Cluster Analysis | 3 | 2023 | 465 | 0.090 |
Why?
| History, 19th Century | 1 | 2011 | 56 | 0.090 |
Why?
| Chile | 2 | 2021 | 16 | 0.090 |
Why?
| Respiratory Sounds | 1 | 2011 | 111 | 0.090 |
Why?
| Estrogen Receptor alpha | 1 | 2012 | 120 | 0.090 |
Why?
| Body Height | 2 | 2023 | 180 | 0.090 |
Why?
| Cardiovascular Diseases | 1 | 2022 | 1724 | 0.090 |
Why?
| History, 21st Century | 1 | 2011 | 162 | 0.090 |
Why?
| South Africa | 3 | 2015 | 162 | 0.090 |
Why?
| Electronic Health Records | 3 | 2021 | 805 | 0.090 |
Why?
| Databases, Genetic | 2 | 2021 | 208 | 0.090 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 274 | 0.090 |
Why?
| History, 20th Century | 1 | 2011 | 273 | 0.090 |
Why?
| Genotyping Techniques | 2 | 2020 | 70 | 0.090 |
Why?
| Mutation | 4 | 2018 | 3364 | 0.090 |
Why?
| Vital Capacity | 1 | 2010 | 277 | 0.080 |
Why?
| Peru | 2 | 2022 | 55 | 0.080 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2023 | 2098 | 0.080 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 1147 | 0.080 |
Why?
| Chromosomes, Human, Pair 8 | 2 | 2019 | 33 | 0.080 |
Why?
| Signal Transduction | 2 | 2019 | 4541 | 0.080 |
Why?
| Africa | 3 | 2017 | 96 | 0.080 |
Why?
| Life Style | 2 | 2022 | 429 | 0.080 |
Why?
| South America | 2 | 2020 | 53 | 0.080 |
Why?
| Americas | 2 | 2018 | 20 | 0.080 |
Why?
| Risk | 3 | 2018 | 819 | 0.070 |
Why?
| Whole Genome Sequencing | 2 | 2018 | 100 | 0.070 |
Why?
| Middle Aged | 9 | 2020 | 26999 | 0.070 |
Why?
| Ants | 1 | 2007 | 27 | 0.070 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 1098 | 0.070 |
Why?
| Linguistics | 1 | 2007 | 26 | 0.070 |
Why?
| Odds Ratio | 3 | 2014 | 962 | 0.070 |
Why?
| Chromosomes, Human, Pair 17 | 2 | 2019 | 57 | 0.070 |
Why?
| Speech | 1 | 2007 | 68 | 0.070 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2022 | 3254 | 0.070 |
Why?
| Child, Preschool | 6 | 2020 | 9133 | 0.070 |
Why?
| Human Genome Project | 2 | 2017 | 14 | 0.070 |
Why?
| Epigenesis, Genetic | 2 | 2022 | 526 | 0.060 |
Why?
| Lung Diseases | 1 | 2012 | 710 | 0.060 |
Why?
| High-Throughput Nucleotide Sequencing | 2 | 2022 | 443 | 0.060 |
Why?
| RNA | 1 | 2011 | 819 | 0.060 |
Why?
| Bias | 2 | 2019 | 179 | 0.060 |
Why?
| Base Sequence | 3 | 2016 | 2114 | 0.060 |
Why?
| Cohort Studies | 4 | 2019 | 4944 | 0.060 |
Why?
| Microsatellite Repeats | 3 | 2011 | 137 | 0.060 |
Why?
| Argentina | 2 | 2015 | 14 | 0.060 |
Why?
| Body Mass Index | 2 | 2023 | 1971 | 0.060 |
Why?
| Polymorphism, Genetic | 2 | 2018 | 621 | 0.060 |
Why?
| Iran | 1 | 2023 | 35 | 0.060 |
Why?
| Los Angeles | 1 | 2023 | 56 | 0.060 |
Why?
| Geography | 2 | 2016 | 181 | 0.060 |
Why?
| Lipoprotein(a) | 1 | 2023 | 51 | 0.050 |
Why?
| Caribbean Region | 2 | 2013 | 19 | 0.050 |
Why?
| Factor X | 1 | 2022 | 24 | 0.050 |
Why?
| Age Factors | 2 | 2020 | 2907 | 0.050 |
Why?
| Factor VII | 1 | 2022 | 26 | 0.050 |
Why?
| Blood Coagulation Factors | 1 | 2022 | 44 | 0.050 |
Why?
| Infant, Newborn | 3 | 2020 | 5077 | 0.050 |
Why?
| Genome, Viral | 1 | 2022 | 121 | 0.050 |
Why?
| Epigenomics | 1 | 2022 | 105 | 0.050 |
Why?
| Loss of Function Mutation | 1 | 2021 | 36 | 0.050 |
Why?
| Genes, Recessive | 1 | 2021 | 72 | 0.050 |
Why?
| Inheritance Patterns | 1 | 2021 | 45 | 0.050 |
Why?
| HLA-A Antigens | 1 | 2021 | 50 | 0.050 |
Why?
| Bronchi | 2 | 2014 | 250 | 0.050 |
Why?
| Quality Control | 1 | 2021 | 147 | 0.050 |
Why?
| Infant | 3 | 2021 | 7979 | 0.050 |
Why?
| China | 1 | 2021 | 163 | 0.050 |
Why?
| Central America | 1 | 2020 | 16 | 0.050 |
Why?
| Ultrasonography | 1 | 2024 | 641 | 0.040 |
Why?
| Blood Proteins | 1 | 2022 | 238 | 0.040 |
Why?
| Longitudinal Studies | 2 | 2020 | 2416 | 0.040 |
Why?
| Aged, 80 and over | 3 | 2020 | 6417 | 0.040 |
Why?
| Sensitivity and Specificity | 1 | 2024 | 1718 | 0.040 |
Why?
| Chromosomes, Human, Pair 12 | 1 | 2019 | 21 | 0.040 |
Why?
| Topography, Medical | 1 | 2019 | 12 | 0.040 |
Why?
| Classification | 1 | 2019 | 19 | 0.040 |
Why?
| Asia, Northern | 1 | 2018 | 1 | 0.040 |
Why?
| Mongolia | 1 | 2018 | 2 | 0.040 |
Why?
| Databases, Nucleic Acid | 1 | 2018 | 33 | 0.040 |
Why?
| Neoplasm Recurrence, Local | 1 | 2024 | 863 | 0.040 |
Why?
| Pharmacogenomic Testing | 1 | 2019 | 54 | 0.040 |
Why?
| Altitude | 1 | 2022 | 409 | 0.040 |
Why?
| Health Equity | 1 | 2019 | 56 | 0.040 |
Why?
| Receptors, Natural Killer Cell | 1 | 2018 | 16 | 0.040 |
Why?
| Hominidae | 1 | 2019 | 80 | 0.040 |
Why?
| Protein Interaction Domains and Motifs | 1 | 2019 | 135 | 0.040 |
Why?
| Reproducibility of Results | 2 | 2018 | 2800 | 0.040 |
Why?
| Structure-Activity Relationship | 1 | 2019 | 511 | 0.040 |
Why?
| Chromosomes, Human, Pair 1 | 1 | 2018 | 68 | 0.040 |
Why?
| Kaplan-Meier Estimate | 1 | 2020 | 815 | 0.040 |
Why?
| New York City | 1 | 2017 | 74 | 0.040 |
Why?
| Prospective Studies | 3 | 2014 | 6264 | 0.040 |
Why?
| Pilot Projects | 1 | 2022 | 1377 | 0.040 |
Why?
| Residence Characteristics | 1 | 2019 | 276 | 0.040 |
Why?
| Software | 1 | 2021 | 541 | 0.040 |
Why?
| Health Status Disparities | 1 | 2019 | 204 | 0.040 |
Why?
| Musculoskeletal Diseases | 1 | 2017 | 55 | 0.040 |
Why?
| Multigene Family | 1 | 2017 | 193 | 0.030 |
Why?
| DNA, Intergenic | 1 | 2016 | 23 | 0.030 |
Why?
| Genetic Heterogeneity | 1 | 2016 | 51 | 0.030 |
Why?
| Placenta | 1 | 2022 | 624 | 0.030 |
Why?
| Molecular Sequence Data | 2 | 2014 | 2790 | 0.030 |
Why?
| Anthropometry | 1 | 2016 | 181 | 0.030 |
Why?
| Sexism | 1 | 2016 | 43 | 0.030 |
Why?
| Ligands | 1 | 2018 | 569 | 0.030 |
Why?
| Genetic Testing | 1 | 2018 | 382 | 0.030 |
Why?
| Membrane Transport Proteins | 1 | 2017 | 137 | 0.030 |
Why?
| Protein Conformation | 1 | 2019 | 822 | 0.030 |
Why?
| Chromosomes, Human, Pair 14 | 1 | 2014 | 16 | 0.030 |
Why?
| HLA-DQ alpha-Chains | 1 | 2014 | 14 | 0.030 |
Why?
| Amino Acid Sequence | 1 | 2019 | 2000 | 0.030 |
Why?
| Crosses, Genetic | 1 | 2014 | 141 | 0.030 |
Why?
| Animals | 5 | 2019 | 32102 | 0.030 |
Why?
| Blood Glucose | 1 | 2023 | 1824 | 0.030 |
Why?
| Databases, Factual | 1 | 2019 | 1138 | 0.030 |
Why?
| Mammography | 1 | 2014 | 107 | 0.030 |
Why?
| Mouth | 1 | 2014 | 67 | 0.030 |
Why?
| Sex Factors | 1 | 2019 | 1736 | 0.030 |
Why?
| Models, Molecular | 1 | 2019 | 1390 | 0.030 |
Why?
| San Francisco | 1 | 2013 | 56 | 0.030 |
Why?
| HeLa Cells | 1 | 2015 | 567 | 0.030 |
Why?
| HapMap Project | 1 | 2013 | 3 | 0.030 |
Why?
| Africa, Northern | 1 | 2013 | 4 | 0.030 |
Why?
| Protein Binding | 1 | 2019 | 1917 | 0.030 |
Why?
| Interleukin-13 | 1 | 2014 | 126 | 0.030 |
Why?
| Neoplasm Invasiveness | 1 | 2014 | 445 | 0.030 |
Why?
| Air Pollutants | 1 | 2016 | 246 | 0.030 |
Why?
| Skin Tests | 1 | 2013 | 130 | 0.030 |
Why?
| Th2 Cells | 1 | 2014 | 157 | 0.030 |
Why?
| Hawaii | 1 | 2012 | 38 | 0.030 |
Why?
| HLA Antigens | 1 | 2014 | 223 | 0.030 |
Why?
| Income | 1 | 2013 | 170 | 0.030 |
Why?
| Genome, Mitochondrial | 1 | 2012 | 27 | 0.030 |
Why?
| Receptors, Estrogen | 1 | 2014 | 372 | 0.020 |
Why?
| Chromosomes, Human, Pair 11 | 1 | 2012 | 58 | 0.020 |
Why?
| Meta-Analysis as Topic | 1 | 2012 | 161 | 0.020 |
Why?
| Markov Chains | 1 | 2012 | 114 | 0.020 |
Why?
| Educational Status | 1 | 2013 | 413 | 0.020 |
Why?
| Insurance, Health | 1 | 2013 | 246 | 0.020 |
Why?
| Canada | 1 | 2012 | 335 | 0.020 |
Why?
| Boston | 1 | 2011 | 74 | 0.020 |
Why?
| DNA Mutational Analysis | 1 | 2012 | 372 | 0.020 |
Why?
| Mitochondrial Proton-Translocating ATPases | 1 | 2011 | 17 | 0.020 |
Why?
| Angola | 1 | 2011 | 1 | 0.020 |
Why?
| Mozambique | 1 | 2011 | 5 | 0.020 |
Why?
| Africa South of the Sahara | 1 | 2011 | 37 | 0.020 |
Why?
| Microfilament Proteins | 1 | 2012 | 126 | 0.020 |
Why?
| Bayes Theorem | 1 | 2012 | 334 | 0.020 |
Why?
| North America | 1 | 2011 | 261 | 0.020 |
Why?
| Pregnancy | 1 | 2022 | 5548 | 0.020 |
Why?
| Molecular Chaperones | 1 | 2011 | 157 | 0.020 |
Why?
| Culture | 1 | 2011 | 125 | 0.020 |
Why?
| Statistics, Nonparametric | 1 | 2011 | 390 | 0.020 |
Why?
| Statistics as Topic | 1 | 2011 | 299 | 0.020 |
Why?
| Time Factors | 1 | 2020 | 6165 | 0.020 |
Why?
| Allergens | 1 | 2013 | 418 | 0.020 |
Why?
| Family | 1 | 2013 | 594 | 0.020 |
Why?
| Reference Values | 1 | 2010 | 744 | 0.020 |
Why?
| Logistic Models | 1 | 2013 | 1856 | 0.020 |
Why?
| Tanzania | 1 | 2008 | 44 | 0.020 |
Why?
| Social Behavior | 1 | 2011 | 269 | 0.020 |
Why?
| Biomarkers, Tumor | 1 | 2014 | 1048 | 0.020 |
Why?
| Inbreeding | 1 | 2007 | 16 | 0.020 |
Why?
| Hypersensitivity | 1 | 2011 | 260 | 0.020 |
Why?
| Linear Models | 1 | 2010 | 776 | 0.020 |
Why?
| DNA-Binding Proteins | 1 | 2014 | 1316 | 0.020 |
Why?
| Cell Line, Tumor | 1 | 2014 | 2751 | 0.020 |
Why?
| Prevalence | 1 | 2013 | 2264 | 0.020 |
Why?
| Transcription Factors | 1 | 2014 | 1528 | 0.020 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2008 | 477 | 0.020 |
Why?
| Reproduction | 1 | 2007 | 180 | 0.020 |
Why?
| Models, Biological | 1 | 2013 | 1646 | 0.020 |
Why?
| Smoking | 1 | 2012 | 1457 | 0.020 |
Why?
| Severity of Illness Index | 1 | 2011 | 2578 | 0.010 |
Why?
| Surveys and Questionnaires | 1 | 2013 | 4665 | 0.010 |
Why?
| Mice | 1 | 2013 | 15052 | 0.010 |
Why?
|
|
Gignoux's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|